New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia.
Jan AstermarkCihan AyManuela CarvalhoRoseline D'OironPhilippe De MoerlooseGerard DolanAndreas GreinacherCedric HermansPål Andre HolmeOlga KatsarouGili KenetRobert KlamrothMaria Elisa MancusoNatascha MarquardtRamiro NúñezIngrid PabingerRobert TaitPaul van der ValkPublished in: Thrombosis and haemostasis (2021)
Our data do not identify a second peak of inhibitor development in older patients with hemophilia. Prophylaxis may be beneficial in older patients with severe, and possibly moderate HA, to retain a tolerant state at a higher age.